199 related articles for article (PubMed ID: 15613434)
1. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
[TBL] [Abstract][Full Text] [Related]
2. Tripartite control of growth hormone secretion in women during controlled estradiol repletion.
Veldhuis JD; Cosma M; Erickson D; Paulo R; Mielke K; Farhy LS; Bowers CY
J Clin Endocrinol Metab; 2007 Jun; 92(6):2336-45. PubMed ID: 17405836
[TBL] [Abstract][Full Text] [Related]
3. Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.
Erickson D; Keenan DM; Mielke K; Bradford K; Bowers CY; Miles JM; Veldhuis JD
J Clin Endocrinol Metab; 2004 Sep; 89(9):4746-54. PubMed ID: 15356089
[TBL] [Abstract][Full Text] [Related]
4. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp.
Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315
[TBL] [Abstract][Full Text] [Related]
5. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
Veldhuis JD; Anderson SM; Kok P; Iranmanesh A; Frystyk J; Ørskov H; Keenan DM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1312-8. PubMed ID: 15001627
[TBL] [Abstract][Full Text] [Related]
6. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
[TBL] [Abstract][Full Text] [Related]
7. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
[TBL] [Abstract][Full Text] [Related]
8. Distinctive inhibitory mechanisms of age and relative visceral adiposity on growth hormone secretion in pre- and postmenopausal women studied under a hypogonadal clamp.
Veldhuis JD; Erickson D; Mielke K; Farhy LS; Keenan DM; Bowers CY
J Clin Endocrinol Metab; 2005 Nov; 90(11):6006-13. PubMed ID: 16091485
[TBL] [Abstract][Full Text] [Related]
9. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
10. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
[TBL] [Abstract][Full Text] [Related]
11. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
[TBL] [Abstract][Full Text] [Related]
12. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
[TBL] [Abstract][Full Text] [Related]
13. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
[TBL] [Abstract][Full Text] [Related]
14. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
Veldhuis JD; Bowers CY
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
[TBL] [Abstract][Full Text] [Related]
15. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.
Soares-Welch C; Farhy L; Mielke KL; Mahmud FH; Miles JM; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2005 Apr; 90(4):2225-32. PubMed ID: 15634714
[TBL] [Abstract][Full Text] [Related]
16. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
[TBL] [Abstract][Full Text] [Related]
17. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
[TBL] [Abstract][Full Text] [Related]
18. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
[TBL] [Abstract][Full Text] [Related]
19. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
Norman C; Rollene NL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
Eur J Endocrinol; 2014 Jan; 170(1):121-9. PubMed ID: 24114435
[TBL] [Abstract][Full Text] [Related]
20. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
